High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis

Koji Ishikawa,1–3 Takashi Nagai,1 Koki Tsuchiya,1 Yusuke Oshita,3 Takuma Kuroda,1 Hiroshi Ito,1 Soji Tani,1 Yusuke Dodo,1 Tomoaki Toyone,1 Katsunori Inagaki1 1Department of Orthopaedic Surgery, Showa University School of Medicine, Tokyo, Japan; 2Department of Orthopaedic and Spine Surgery...

Full description

Saved in:
Bibliographic Details
Main Authors: Ishikawa K, Nagai T, Tsuchiya K, Oshita Y, Kuroda T, Ito H, Tani S, Dodo Y, Toyone T, Inagaki K
Format: article
Language:EN
Published: Dove Medical Press 2018
Subjects:
Denosumab
Symptomatic hypocalcemia
High bone turnover
No renal impairment
Geriatrics
RC952-954.6
Online Access:https://doaj.org/article/19c9bed2c2ce45dd91f6fa463635bb72
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/19c9bed2c2ce45dd91f6fa463635bb72

Similar Items